Your browser doesn't support javascript.
loading
Impact of single round of low dose CT lung cancer screening on cause of mortality in different socio-economic groups: a post-hoc analysis of long-term follow-up of the UKLS trial.
Davies, Michael P A; Vulkan, Daniel; Gabe, Rhian; Duffy, Stephen W; Field, John K.
Afiliación
  • Davies MPA; Department of Molecular and Clinical Cancer Medicine Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK.
  • Vulkan D; Centre for Evaluation and Methods, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
  • Gabe R; Centre for Evaluation and Methods, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
  • Duffy SW; Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
  • Field JK; Department of Molecular and Clinical Cancer Medicine Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK.
Lancet Reg Health Eur ; 42: 100936, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38813535
ABSTRACT

Background:

Lower socioeconomic status, as measured by the Index of Multiple Deprivation (IMD), is associated with higher rates of smoking-related disease mortality, and with poor uptake of cancer screening. Here we explore whether socioeconomic status impacts the effectiveness of a single round of low-dose-CT screening, or impacts other causes of death, in the UKLS LDCT screening trial.

Methods:

IMD quintiles were defined according to UK-wide data, with the deprived group defined as the lower two quintiles (Q1-2) and the less deprived as Q3-5. Follow-up data was obtained for lung cancer diagnosis (median follow-up 9.1 years) and cause of death (median follow-up 9.9 years). Outcomes were compared based on IMD group and trial arm (CT or control).

Findings:

More deprived quintiles were less likely to respond to the questionnaire, but this population was more likely to be selected for screening by the LLP risk model. Lower IMD quintiles benefitted from low-dose-CT screening in terms of lung cancer survival (HR 1.89, 95% CI 1.16-3.08) to the same extent as upper quintiles (HR 1.87, 95% CI 1.07-3.26). However, there was a bigger impact on deaths due to COPD and emphysema in more deprived quintiles.

Interpretation:

Whilst LDCT screening benefit for lung cancer was similar, significant impact on the rates of death from other smoking-related diseases, notably COPD and emphysema, was seen primarily in lower socioeconomic groups. Future research is required to confirm how lung cancer screening benefits other disease outcomes.

Funding:

NIHR Health Technology Assessment Programme; NIHR Policy Research programme; Roy Castle Lung Cancer Foundation.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Lancet Reg Health Eur Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Lancet Reg Health Eur Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido